Glucose-dependent Insulinotropic Polypeptide: Blood Glucose Stabilizing Effects in Patients With Type 2 Diabetes-Reference-Cited by-同舟云学术

Glucose-dependent Insulinotropic Polypeptide: Blood Glucose Stabilizing Effects in Patients With Type 2 Diabetes

Published:2014-03-01 Issue:3 Volume:99 Page:E418-E426
ISSN:0021-972X
Container-title:The Journal of Clinical Endocrinology & Metabolism
language:en
Short-container-title:

Author:

Christensen Mikkel B.¹,Calanna Salvatore¹²,Holst Jens J.³,Vilsbøll Tina¹,Knop Filip K.¹³

Affiliation:

1. Diabetes Research Division (M.B.C., S.C., T.V., F.K.K.), Department of Medicine, Copenhagen University Hospital Gentofte, Hellerup DK-2900, Denmark

2. Department of Clinical and Molecular Biomedicine (S.C.), University of Catania, 95124 Catania, Italy

3. Department of Biomedical Sciences (J.J.H., M.B.C., F.K.K.), the Panum Institute; University of Copenhagen, DK-2100 Copenhagen, Denmark

Publisher

The Endocrine Society

Subject

Biochemistry (medical),Clinical Biochemistry,Endocrinology,Biochemistry,Endocrinology, Diabetes and Metabolism

Link

http://academic.oup.com/jcem/article-pdf/99/3/E418/11158121/jcemE418.pdf

Reference38 articles.

1. Preserved incretin activity of glucagon-like peptide 1 [7–36 amide] but not of synthetic human gastric inhibitory polypeptide in patients with type-2 diabetes mellitus;Nauck;J Clin Invest,1993

2. Both GLP-1 and GIP are insulinotropic at basal and postprandial glucose levels and contribute nearly equally to the incretin effect of a meal in healthy subjects;Vilsbøll;Regul Pept,2003

3. Glucose-dependent insulinotropic polypeptide: a bifunctional glucose-dependent regulator of glucagon and insulin secretion in humans;Christensen;Diabetes,2011

4. Gastric inhibitory polypeptide (GIP) dose-dependently stimulates glucagon secretion in healthy human subjects at euglycaemia;Meier;Diabetologia,2003

5. The effects of glucose-dependent insulinotropic polypeptide infused at physiological concentrations in normal subjects and type 2 (non-insulin-dependent) diabetic patients on glucose tolerance and B-cell secretion;Jones;Diabetologia,1987

Cited by 84 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comparison of the effects of Liraglutide, Tirzepatide, and Retatrutide on diabetic kidney disease in db/db mice;Endocrine;2024-08-30

2. Investigational and emerging gastric inhibitory polypeptide (GIP) receptor-based therapies for the treatment of obesity;Expert Opinion on Investigational Drugs;2024-07-17

3. Safety of native glucose-dependent insulinotropic polypeptide in humans;Peptides;2024-07

4. DR10627, a Novel Dual Glucagon‑like Peptide‑1 and Gastric Inhibitory Polypeptide Receptor Agonist for the Treatment of Obesity and Type 2 Diabetes Mellitus;Diabetes, Metabolic Syndrome and Obesity;2024-04

5. The preclinical discovery and clinical evaluation of tirzepatide for the treatment of type 2 diabetes;Expert Opinion on Drug Discovery;2024-03-05